Literature DB >> 8929649

Veno-occlusive disease in hypereosinophilic syndrome.

K Kojima1, T Sasaki.   

Abstract

A 68-year-old male with hypereosinophilic syndrome developed acute hepatic veno-occlusive disease. The diagnosis of veno-occlusive disease was made mainly based on clinical symptoms and hepatic phlebography. Although veno-occlusive disease caused hepatic failure complicated with massive ascites, consciousness disturbance and coagulation abnormality, all of these manifestations subsided shortly after the start of corticosteroid therapy for hypereosinophilic syndrome. Since eosinophils cause direct tissue damage and local hypercoagulation, it is suggested that hypereosinophilia may be actively involved in the development of hepatic veno-occlusive disease in the course of the disease state.

Entities:  

Mesh:

Year:  1995        PMID: 8929649     DOI: 10.2169/internalmedicine.34.1194

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

1.  Sinusoidal obstructive syndrome with hypereosinophilia successfully treated with prednisolone.

Authors:  Yuichi Yamaga; Yukio Tsugihashi; Takefumi Nakamura; Takanori Taniguchi; Gen Honjou; Masayoshi Kage
Journal:  Clin J Gastroenterol       Date:  2011-11-12

2.  The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states.

Authors:  Jian-Guo Wang; Shawn A Mahmud; Jacob A Thompson; Jian-Guo Geng; Nigel S Key; Arne Slungaard
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

3.  Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder; Mustafa Delibalta
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

4.  Sudden death of a patient with primary hypereosinophilia, colon tumours, and pulmonary emboli.

Authors:  K Uemura; M Nakajima; N Yamauchi; M Fukayama; K Yoshida
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

5.  Eosinophilia and first-line coagulation testing.

Authors:  Giuseppe Lippi; Martina Montagnana; Gian Luca Salvagno; Massimo Franchini; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-07-10       Impact factor: 2.300

Review 6.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 7.  Eosinophils as Major Player in Type 2 Inflammation: Autoimmunity and Beyond.

Authors:  Marco Folci; Giacomo Ramponi; Ivan Arcari; Aurora Zumbo; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  A patient with hypereosinophilic syndrome that manifested with acquired hemophilia and elevated IgG4: a case report.

Authors:  Yoshiro Nagao; Hiromi Yamanaka; Hiromasa Harada
Journal:  J Med Case Rep       Date:  2012-02-14

9.  Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.

Authors:  Lucyna Mastalerz; Magdalena Celińska-Lӧwenhoff; Piotr Krawiec; Bogdan Batko; Witold Tłustochowicz; Anetta Undas
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.